ARG10168

anti-HIV1 p24 antibody [473] (HRP)

anti-HIV1 p24 antibody [473] (HRP) for ELISA and HIV

Immune System antibody; Microbiology and Infectious Disease antibody

Overview

Product Description HRP-conjugated Mouse Monoclonal antibody [473] recognizes HIV-1 p24
Tested Reactivity HIV
Tested Application ELISA
Host Mouse
Clonality Monoclonal
Clone 473
Isotype IgG1,k
Target Name HIV1 p24
Antigen Species HIV
Immunogen Purified recombinant HIV-1 p24 (core protein)
Conjugation HRP

Application Instructions

Application Note ELISA: In combination with anti-HIV-1 p24 capture antibody mAb clone 340 (Cat. No. ARG10167), this HRP conjugated antibody can be used as a tracer antibody for HIV-1 p24 detection in sandwich ELISA.

* The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Properties

Form Liquid
Purification Protein G affinity purified
Buffer 0.01M PBS (pH 7.2) and 50% Glycerol
Stabilizer 50% Glycerol
Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Keep the antibody in the dark and keep protected from prolonged exposure to light. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Background P24 is the 24KDa, non-glycosylated protein that forms the Core (Capisid) of human immunodeficiency virus (HIV) and other Lentiviruses in the Retroviridiae family. P24 is expressed immediately after HIV infection and is detectable before host HIV antibody can be detected. Hence, HIV p24 is currently the target for early diagnosis of HIV acute infection.
Research Area Immune System antibody; Microbiology and Infectious Disease antibody

Clone References

Multiple tandem copies of conserved gp41 epitopes incorporated in gag virus-like particles elicit systemic and mucosal antibodies in an optimized heterologous vector delivery regimen.

Jain S et al.
Vaccine.,  (2010)

publication_link

 

hr_line